Short-Term Course Of Budesonide May Lead To Clinical Remission In Around 80% Of Patients With Lymphocytic Colitis, Study Suggests
Source: Lymphocytic Colitis Responds Rapidly to Budesonide | Medpage Today
Source: Lymphocytic Colitis Responds Rapidly to Budesonide | Medpage Today